When will small molecule lactate dehydrogenase inhibitors realize their potential in the cancer clinic?
In this review article, brought to MedChemNet users by our sister journal Future Medicinal Chemistry, the authors discuss their views on the promise of small molecule lactate dehydrogenase and how they may translate into the cancer clinic.
Please sign in or register for FREE to view this content
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.